Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing.

Saved in:
Bibliographic Details
Title: Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing.
Authors: Khanna R; Queensland Institute of Medical Research, Bancroft Centre, Brisbane, Australia., Burrows SR, Steigerwald-Mullen PM, Moss DJ, Kurilla MG, Cooper L
Source: International immunology [Int Immunol] 1997 Oct; Vol. 9 (10), pp. 1537-43.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: [Oxford University Press Country of Publication: England NLM ID: 8916182 Publication Model: Print Cited Medium: Print ISSN: 0953-8178 (Print) Linking ISSN: 09538178 NLM ISO Abbreviation: Int Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0953-8178
DOI:10.1093/intimm/9.10.1537